Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLACNASDAQ:QNRXOTCMKTS:SIGYOTCMKTS:UAHC On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLACBellevue Life Sciences Acquisition$1.54-4.9%$1.34$3.01▼$13.40$6.22M-0.0820,837 shs194,958 shsQNRXQuoin Pharmaceuticals$8.70+3.6%$7.53$5.01▼$54.95$5.13M1.43137,485 shs13,561 shsSIGYSigyn Therapeutics$2.75$3.32$2.49▼$5.75$4.43M-1.18140 shsN/AUAHCUnited American Healthcare$0.01-1.4%$0.01$0.01▼$0.11$1.59M-1.551,019 shs6,098 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLACBellevue Life Sciences Acquisition0.00%+9.22%+27.27%-9.94%-85.67%QNRXQuoin Pharmaceuticals0.00%+3.82%-2.25%-16.02%-59.41%SIGYSigyn Therapeutics0.00%0.00%-22.10%-31.25%-47.62%UAHCUnited American Healthcare0.00%-2.16%-3.55%+3.82%-43.33%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AN/AN/AQNRXQuoin Pharmaceuticals0.8527 of 5 stars0.05.00.00.00.60.01.3SIGYSigyn TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLACBellevue Life Sciences Acquisition 0.00N/AN/AN/AQNRXQuoin Pharmaceuticals 0.00N/AN/AN/ASIGYSigyn Therapeutics 0.00N/AN/AN/AUAHCUnited American Healthcare 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/A$35.47 per shareN/ASIGYSigyn TherapeuticsN/AN/AN/AN/A($2.78) per shareN/AUAHCUnited American HealthcareN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLACBellevue Life Sciences AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/AQNRXQuoin Pharmaceuticals-$8.96M-$48.81N/AN/AN/AN/A-148.97%-77.23%8/14/2025 (Estimated)SIGYSigyn Therapeutics-$3.34M-$4.57N/A∞N/AN/AN/A-2,014.27%N/AUAHCUnited American Healthcare$240KN/A0.00∞N/AN/AN/AN/AN/ALatest UAHC, BLAC, QNRX, and SIGY EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/20/2025Q1 2025SIGYSigyn TherapeuticsN/A-$0.42N/A-$0.42N/AN/A5/13/2025Q1 2025QNRXQuoin Pharmaceuticals-$3.85-$6.50-$2.65-$6.50N/AN/A4/15/2025Q4 2024SIGYSigyn TherapeuticsN/A-$2.51N/A-$2.51N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLACBellevue Life Sciences AcquisitionN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/AN/ASIGYSigyn TherapeuticsN/AN/AN/AN/AN/AUAHCUnited American Healthcare$0.08588.24%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLACBellevue Life Sciences AcquisitionN/AN/AN/AQNRXQuoin PharmaceuticalsN/A2.572.57SIGYSigyn TherapeuticsN/A0.010.01UAHCUnited American HealthcareN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLACBellevue Life Sciences Acquisition55.30%QNRXQuoin Pharmaceuticals8.63%SIGYSigyn Therapeutics10.01%UAHCUnited American HealthcareN/AInsider OwnershipCompanyInsider OwnershipBLACBellevue Life Sciences Acquisition33.67%QNRXQuoin Pharmaceuticals3.70%SIGYSigyn Therapeutics78.46%UAHCUnited American Healthcare14.31%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLACBellevue Life Sciences AcquisitionN/A4.04 million2.68 millionNot OptionableQNRXQuoin Pharmaceuticals4590,000566,000Not OptionableSIGYSigyn Therapeutics51.61 million346,000Not OptionableUAHCUnited American Healthcare31117.06 million100.31 millionNot OptionableUAHC, BLAC, QNRX, and SIGY HeadlinesRecent News About These CompaniesUnited American Healthcare CorpShsMay 6, 2025 | markets.businessinsider.comUnited Healthcare data breach may have affected 190 million AmericansJanuary 27, 2025 | msn.comUnitedHealth CEO: American healthcare needs to be "less complex and less confusing'January 17, 2025 | msn.comUnitedHealth tops profit forecasts but medical costs linger for health care giantJanuary 16, 2025 | msn.comNews Wrap: United Healthcare CEO killed in brazen and targeted attack, New York police sayDecember 5, 2024 | pbs.orgHH Health System, United Healthcare reach agreementNovember 14, 2024 | elkvalleytimes.comUnited Healthcare reaches deal with Huntsville Hospital Health SystemNovember 14, 2024 | decaturdaily.comHow will a Trump presidency reshape US public health? A look at his plans.November 13, 2024 | usatoday.comDreamers eligible for health insurance through Covered California for first time this yearNovember 8, 2024 | thecalifornian.comDuke Health, UnitedHealthcare reach multi-year agreement, impacts over 172K patientsNovember 3, 2024 | msn.comAs ACA sign ups start, more Americans have health insurance than ever. Will it last?November 2, 2024 | msn.comUSA Health sets gala to celebrate health care workers’ impact on patientsOctober 31, 2024 | msn.comUnitedHealth Confirms Change Healthcare Data Breach Impacted 100 Million AmericansOctober 29, 2024 | cpomagazine.comMore than 100 million Americans had their health data exposed in a UnitedHealth hackOctober 26, 2024 | 9to5mac.comCyberattack at UnitedHealth subsidiary Change Healthcare affected 100M AmericansOctober 24, 2024 | startribune.comMore than 1,500 physicians call on Trump to release health care planOctober 18, 2024 | msn.comNew center aims to enhance public health preparedness in Utah and beyondOctober 11, 2024 | msn.comThe Plastic-Free Movement: Redefining Healthcare Disinfection for a Healthier PlanetOctober 9, 2024 | beckershospitalreview.comHealth Care Is on the Ballot AgainOctober 4, 2024 | theatlantic.comNew United Against the Flu toolkit urges vaccination before peak respiratory virus seasonSeptember 28, 2024 | aha.orgNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All Headlines3 Defense Stocks That Will Profit From a Golden DomeBy Chris Markoch | May 30, 2025View 3 Defense Stocks That Will Profit From a Golden DomeIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeIntel's Turnaround Strategy Shifts From Planning to Attack ModeBy Jeffrey Neal Johnson | June 20, 2025View Intel's Turnaround Strategy Shifts From Planning to Attack ModeSuper Micro Computer Stock Finding Upside With NVIDIA's BlackwellBy Gabriel Osorio-Mazilli | May 30, 2025View Super Micro Computer Stock Finding Upside With NVIDIA's BlackwellNew Catalysts to Drive NVIDIA’s Stock Price Even HigherBy Thomas Hughes | June 16, 2025View New Catalysts to Drive NVIDIA’s Stock Price Even HigherUAHC, BLAC, QNRX, and SIGY Company DescriptionsBellevue Life Sciences Acquisition NASDAQ:BLAC$1.54 -0.08 (-4.94%) As of 06/20/2025Bellevue Life Sciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities in the healthcare industry. The company was incorporated in 2020 and is based in Bellevue, Washington. Bellevue Life Sciences Acquisition Corp. operates as a subsidiary of Bellevue Global Life Sciences Investors LLC.Quoin Pharmaceuticals NASDAQ:QNRX$8.70 +0.30 (+3.57%) Closing price 06/20/2025 03:59 PM EasternExtended Trading$8.42 -0.28 (-3.22%) As of 06/20/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. The company was founded in 2018 and is based in Ashburn, Virginia.Sigyn Therapeutics OTCMKTS:SIGY$2.75 0.00 (0.00%) As of 06/20/2025Sigyn Therapeutics, Inc., a development-stage company, provides therapeutic solutions in the United States. Its lead product candidate is Sigyn Therapy, a broad-spectrum blood purification technology designed to treat pathogen-associated inflammatory disorders, including endotoxemia and inflammation in end-stage renal disease patients, sepsis, community acquired pneumonia, drug resistant bacterial infections, and emerging pandemic threats. The company is also involved in evaluating the Sigyn Therapy to address various therapeutic targets, including endotoxin; peptidoglycan and lipoteichoic acid; viral pathogens; hepatic toxins; and tumor necrosis factor alpha, interleukin-1 beta, and interleukin 6, which are pro-inflammatory cytokines. In addition, it develops ChemoPrep to enhance the tumor site delivery of chemotherapy; ChemoPure to reduce treatment toxicity and inhibit the spread of cancer metastasis; and ImmunePrep to enhance the potential efficacy of immunotherapeutic antibodies. Sigyn Therapeutics, Inc. was founded in 2019 and is headquartered in San Diego, California.United American Healthcare OTCMKTS:UAHC$0.01 0.00 (-1.45%) As of 06/20/2025 09:52 AM EasternUnited American Healthcare Corporation, through its subsidiaries, provides contract manufacturing services to the medical device industry. It also focuses on the production of natural rubber. The company was incorporated in 1983 and is based in Chicago, Illinois. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas New All-Time Highs Coming for Broadcom? Wall Street Says Yes Smith & Wesson Stock Falls on Earnings Miss, Tariff Woes Marvell's New AI Chip Deals Capture Wall Street’s Attention Super Micro Computer Stock's Rally Backed by Strong Financials Forget the Fed: Home Depot Is the Real Gauge of the U.S. Consumer GE Aerospace Turns Engines Into Long-Term Profits 3 Reasons AMD Could Be the Hottest Stock of the Summer Analysts Keep Boosting Taiwan Semiconductor Stock—Here's Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
